3 options
Stem cells and regenerative medicine Volume 6, Molecular and cellular mechanisms / Philippe Taupin.
- Format:
- Book
- Author/Creator:
- Taupin, Philippe.
- Series:
- Cell biology research progress.
- Cell biology research progress
- Language:
- English
- Subjects (All):
- Stem cells.
- Regenerative medicine.
- Physical Description:
- 1 online resource (154 p.)
- Edition:
- 1st ed.
- Other Title:
- Molecular and cellular mechanisms
- Place of Publication:
- New York : Nova Science Publishers, c2011.
- Language Note:
- English
- Summary:
- Stem cells are the building blocks of the body. They can develop into any of the cells that make up our bodies. Stem cells carry a lot of hope for the treatment of a broad range of diseases and injuries, spanning from cancers, diabetes, genetic diseases, graft-versus-host disease, eye, heart and liver diseases, inflammatory and autoimmune disorders, to neurological diseases and injuries, particularly neurodegenerative diseases, like Alzheimer's and Parkinson's diseases, cerebral strokes, and traumatic brain and spinal cord injuries. Stem cell research is therefore as important for understanding the Physio- and pathology of the body as for development and therapy as well as for understanding the nervous system. This book provides an overview and in-depth analysis of recent developments in stem cell research and therapy.
- Contents:
- Intro
- STEM CELLS AND REGENERATIVE MEDICINE. VOLUME 5. PATENTS AND CLINICAL TRIALS
- Contents
- Preface
- Introduction: Therapeutic Neuronal Stem Cells: Patents at the Forefront*
- Abstract
- 1. Background
- 2. Neural Stem Cells, Therapeutic Potential and Patents
- 3. Expert Opinion
- Acknowledgments
- References**
- Chapter I Adult Neurogenesis and Pharmacology in Alzheimer's Disease and Depression
- Introduction
- Adult Neurogenesis in Alzheimer's Disease
- Adult Neurogenesis in Depression
- Discussion
- Conclusion and Perspectives
- References
- Chapter II Adult Neurogenesis in the Pathogenesis of Alzheimer's Disease
- Chapter III Therapeutic Potential of Adult Neural Stem Cells*
- Neural Progenitor and Stem Cells
- Neural Progenitor and Stem Cells in Vitro
- Origin of Newly Generated Neuronal Cells in the Adult Brain
- Therapeutic Potential of Adult NSCs
- Cellular Therapy
- Gene Therapy
- Current and Future Developments
- Chapter IV Human Neural Progenitor and Stem Cells*
- 1. Introduction
- 2. Chemistry
- 2.1 Proliferation Medium
- 2.2 Culture of Human Fetal Neural Progenitor and Stem Cells
- 3. Biology and Action
- 3.1 Growth Rate
- 3.2 Immunocytofluorescence
- 3.3 Differentiation of Human Fetal Neural Progenitor and Stem Cells
- 4. Expert Opinion
- Chapter V Cryopreservation of Early Postmitotic Neuronal Cells in Culture*
- 2.1 Defined Derivation Medium
- 2.1.1 Defined Derivation Medium #1
- 2.1.2 Defined Medium #2
- 2.1.3 Defined Medium #3
- 2.2 Induction Medium
- 2.2.1 Induction Medium.
- 2.3 Production of Neural Progenitor Cells from Embryonic Stem Cells
- 2.4 Induction of Neural Progenitor Cells into Neuronal or Neural-Like Cells
- 2.5 Cryopreservation
- 2.6 Thawing Cryopreserved Cells
- 2.7 Cultivation
- Chapter VI Adult Neural Stem Cells for the Treatment of Neuroinflammation*
- 3.1 Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis
- 3.2 Syngeneic Transplantation
- 3.3 In Situ Proliferation of Transplanted Anscs
- 3.4 Immunocytology and Immunohistology
- Chapter VII Adult Periodontal-Derived Neural Progenitor and Stem Cells*
- 2.1 Periodontal Tissue
- 2.2 Cell Culture
- 2.3 Differentiation
- 2.4 Immunocytology
- 2.5 Organotypic Hippocampal Slice Cultures
- 2.6 Further Studies
- Chapter VIII Magnetic Resonance Imaging for Monitoring Neurogenesis in the Adult Hippocampus*
- 2.1 Experimental Study in Rats
- 2.2 MRI Scanning in Rats
- 2.3 Histology
- 2.4 Epidemiological Study
- 2.5 MRI Protocol in Human Subjects
- Chapter IX Apigenin and Related Compounds Stimulate Adult Neurogenesis*
- 2.1 Compounds and Derivatives
- 2.2 Synthesis
- 3.1 Animal Studies
- 3.1.1 Intraperitoneal Administration of Apigenin
- 3.1.2 Oral Administration of Apigenin and Epicatechin
- 3.2 Immunohistology
- 3.3 Cell Culture
- Acknowledgments.
- References**
- Chapter X Nootropic Agents Stimulate Neurogenesis*
- 2.1 Cell Culture
- 2.2 Differentiation
- 2.3 Immunocytochemistry
- 2.4 Novel Object Recognition Task
- Chapter XI Fourteen Compounds and their Derivatives for the Treatment of Diseases and Injuries Characterized by Reduced Neurogenesis and Neurodegeneration*
- 3.1 Cell Culture
- 3.2 Immunocytology
- 3.3 Apoptosis
- 3.4 Necrosis
- 3.5 Neuron Dysfunction
- Chapter XII Brevetoxin Derivative Compounds for Stimulating Neuronal Growth*
- 3.1 Primary Cell Culture of Neocortical Neurons
- Chapter XIII OTI-010 Osiris Therapeutics/JCR Pharmaceuticals*
- Summary
- Synthesis and SAR
- Preclinical Development
- In Vitro
- In Vivo
- Toxicity
- Clinical Development
- GVHD
- Transplantation in Cancer Patients
- Crohn's Disease
- Metabolism and Pharmacokinetics
- Side Effects and Contraindications
- Patent Summary
- Current Opinion
- Licensing
- JCR Pharmaceuticals Co Ltd
- Chapter XIV ADA-Transduced Hematopoietic Stem Cell Therapy for ADA-SCID
- Phase I/II
- References*
- Index.
- Notes:
- Description based upon print version of record.
- Includes bibliographical references and index.
- ISBN:
- 1-61761-388-6
- OCLC:
- 923660004
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.